Genotyping of noroviruses from patients of the Pilsen University Hospital in the Czech Republic, 2017–2020
Authors:
P. Pazdiora 1,2; P. Vašíčková 3; M. Krzyžánková 3
Authors‘ workplace:
Oddělení epidemiologie Fakultní nemocnice v Plzni, Plzeň
1; Ústav epidemiologie Lékařské fakulty v Plzni, Univerzita Karlova, Plzeň
2; Výzkumný ústav veterinárního lékařství, Brno
3
Published in:
Epidemiol. Mikrobiol. Imunol. 70, 2021, č. 4, s. 233-240
Category:
Original Papers
Overview
Objective: Noroviruses are members of the Caliciviridae family and are currently segregated into at least 10 genogroups. The distribution of these viruses in the Czech Republic has not yet been investigated in detail. A pilot study was performed to contribute to the overall knowledge and understanding of norovirus circulation in the population. Clinical specimens from patients diagnosed with norovirus infection during their hospitalization at the Pilsen University Hospital were genotyped.
Material and methods: A total of 118 patients were diagnosed with norovirus infection between July 2017 and March 2020. Stool samples from patients presenting with gastroenteritis were routinely screened by the RIDA®QUICK Norovirus Test (R-Biopharm AG), a rapid chromatographic immunoassay for the qualitative detection of Norovirus genogroups I and II, according to the manufacturer’s instructions. Norovirus positive samples were subsequently analysed by molecular biological methods. Stool suspensions (10%) were prepared with phosphate-buffered saline, and nucleic acid was extracted using the QIAamp Viral RNA kit (Qiagen) according to the manufacturer’s instructions. To investigate the genotype distribution, RT-PCR targeting specific sections of the norovirus genome (region C) was employed, followed by purification of PCR products using the QIAquick PCR Purification Kit (Qiagen) and sequencing (Eurofins Genomics). The sequences obtained were analysed by the MEGA X software, and the results of phylogenetic analyses were confirmed by Norovirus Typing Tool Version 2.0 (https://www.rivm.nl/mpf/typingtool/ norovirus/.
Results: During the study period, 14 norovirus genotypes or genogroup variants NoV GI, NoV GII and NoV GIX (previously NoV GII.15) were identified. The major genotype NoV GII.4 Sydney-2012 accounted for a total of 70.3% of norovirus gastroenteritis cases. This norovirus variant was detected in 24 months out of 34 months of the study period. In general, the number of norovirus infections increased during autumn and winter months (October to March) when 68 (57.6%) cases were diagnosed. Although norovirus infection was confirmed in all age categories (age range 0–96 years, median 8, mean 27.9), the statistical analysis revealed a significant difference in the incidence of NoV GII.4 infection between the age group 0–4 years and older patients (χ2 = 3.95, P = 0.047). Many patients (51) were residents of the Pilsen-city district. The case history data showed that 35 of them (29.7%) had another family member who developed symptoms of gastroenteritis at the time of the onset of their infection.
Conclusion: The pilot study is the first attempt to map the molecular epidemiology of noroviruses, not only in the Pilsen Region but also in the whole Czech Republic. Despite the relatively low number of officially reported cases, noroviruses are undoubtedly one of the most important causes of gastroenteritis in this country. Further studies are therefore necessary to expand the body of knowledge of their ecology and circulation.
Keywords:
Gastroenteritis – noroviruses – genotypes – seasonal incidence – infections in children
Sources
1. Ahmed SM, Hall AJ, Robinson AE, et al. Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis. Lancet Infect Dis, 2014;14(8):725–730.
2. Bartsch SM, O‘Shea KJ, Lee BY. The Clinical and Economic Burden of Norovirus Gastroenteritis in the United States. J Infect Dis, 2020;222(11):1910–1919.
3. Brown JR, Shah D, Breuer J. Viral gastrointestinal infections and norovirus genotypes in a paediatric UK hospital, 2014–2015. J Clin Virol, 2016;84:1–6.
4. Carmona-Vicente N, Fernández-Jiménez M, Ribes JM, et al. Norovirus infections and seroprevalence of genotype GII.4-specific antibodies in a Spanish population. J Med Virol, 2015;87(4):675– 682.
5. de Graaf M, van Beek J, Koopmans MP. Human norovirus transmission and evolution in a changing world. Nat Rev Microbiol, 2016;14(7):421–433.
6. Fajfr M, Štěpánová V, Plíšková L, et al. Virové gastroenteritidy v regionu východních Čech (Viral gastroenteritis in Eastern Bohemia Region of the Czech Republic). Epidemiol Mikrobiol Imunol, 2014;63(2):88–91.
7. GBD 2016 Diarrhoeal Disease Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis, 2018;18(11):1211–1228.
8. Hasing ME, Lee BE, Qiu Y, et al. Changes in norovirus genotype diversity in gastroenteritis outbreaks in Alberta, Canada: 2012– 2018. BMC Infect Dis, 2019;19(1):177.
9. Huhti L, Szakal ED, Puustinen L, et al. Norovirus GII-4 causes a more severe gastroenteritis than other noroviruses in young children. J Infect Dis, 2011;203(10):1442–1444.
10. Huvarova V, Kralik P, Vasickova P, et al. Tracing of Selected Viral, Bacterial, and Parasitic Agents on Vegetables and Herbs Originating from Farms and Markets. J Food Sci, 2018;83(12):3044– 3053.
11. Chen C, Yan JB, Wang HL, et al. Molecular epidemiology and spatiotemporal dynamics of norovirus associated with sporadic acute gastroenteritis during 2013–2017, Zhoushan Islands, China. PLoS One, 2018;13(7):e0200911.
12. Chhabra P, de Graaf M, Parra GI, et al. Updated classification of norovirus genogroups and genotypes. J Gen Virol, 2019;100(10):1393–1406.
13. Chhabra P, Graaf M, Parra GI, et al. Corrigendum: Updated classification of norovirus genogroups and genotypes. J Gen Virol, 2020;101(8):893.
14. Kaevska M, Videnska P, Vasickova P. Changes in Microbial Composition of Wastewater During Treatment in a Full-Scale Plant. Curr Microbiol, 2016;72(2):128–132.
15. Kirk MD, Pires SM, Black RE, et al. World Health Organization Estimates of the Global and Regional Disease Burden of 22 Foodborne Bacterial, Protozoal, and Viral Diseases, 2010: A Data Synthesis. PLoS Med, 2015;12(12):e1001921.
16. Kitajima M, Oka T, Haramoto E, et al. Seasonal distribution and genetic diversity of genogroups I, II, and IV noroviruses in the Tamagawa River, Japan. Environ Sci Technol, 2010;44(18):7116– 7122.
17. Kitajima M, Haramoto E, Phanuwan C, et al. Molecular detection and genotyping of human noroviruses in influent and effluent water at a wastewater treatment plant in Japan. J of Appl Microbiol, 2012; 112:605–613.
18. Koo HS, Lee MO, Ku PT, et al. Molecular epidemiology of norovirus in asymptomatic food handlers in Busan, Korea, and emergence of genotype GII.17. J Microbiol, 2016;54(10):686– 694.
19. Korcinska MR, Dalsgaard Bjerre K, Dam Rasmussen L, et al. Detection of norovirus infections in Denmark, 2011–2018. Epidemiol Infect, 2020;148:e52.
20. Kowalzik F, Riera-Montes M, Verstraeten T, et al. The burden of norovirus disease in children in the European Union. Pediatr Infect Dis J, 2015;34(3):229–234.
21. Kowalzik F, Binder H, Zöller D, et al. Norovirus Gastroenteritis among Hospitalized Patients, Germany, 2007–2012. Emerg Infect Dis, 2018;24(11):2021–2028.
22. Kroneman A, Vennema H, Deforche K, et al. An automated genotyping tool for enteroviruses and noroviruses. J Clin Virol, 2011; 51(2):121–125.
23. Krutova M, Briksi A, Tkadlec J, et al. Evaluation of a Gastrointestinal Pathogen Panel Immunoassay in Stool Testing of Patients with Suspected Clostridioides (Clostridium) difficile Infection. J Clin Microbiol, 2019;57(10):e00710–00719.
24. Kumar S, Stecher G, Li M, et al. MEGA X: Molecular Evolutionary Genetics Analysis across computing platforms. Mol Biol Evol, 2018;35:1547–1549.
25. Lopman BA, Steele D, Kirkwood CD, et al. The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control. PLoS Med, 2016;13(4):e1001999.
26. Manso CF, Romalde JL. Molecular epidemiology of norovirus from patients with acute gastroenteritis in northwestern Spain. Epidemiol Infect, 2015;143(2):316–324.
27. Mattison CP, Cardemil CV, Hall AJ. Progress on norovirus vaccine research: public health considerations and future directions. Expert Rev Vaccines, 2018;17(9):773–784.
28. Niendorf S, Jacobsen S, Faber M, et al. Steep rise in norovirus cases and emergence of a new recombinant strain GII.P16-GII.2, Germany, winter 2016. Euro Surveill, 2017;22(4):30447.
29. Paklonskaya NU, Amvrosieva TV, Dziadziulia KL, et al. Norovirus infection in Belarus: occurrence and molecular epidemiology. Cent Eur J Public Health, 2015;23(1):69–72.
30. Pazdiora P, Táborská J, Švecová M, et al. Diagnostika norovirových infekcí u hospitalizovaných dětí a mladistvých s akutní gastroenteritidou. Plzeňská studie (The diagnosis of norovirus infections in hospitalized children and adolescents with acute gastroenteritis: a study from Pilsen, Czech Republic. Epidemiol Mikrobiol Imunol, 2009;58(4):167–172.
31. Puustinen L, Blazevic V, Salminen M, et al. Noroviruses as a major cause of acute gastroenteritis in children in Finland, 2009–2010. Scand J Infect Dis, 2011;43(10):804–808.
32. Siafakas N, Zerva L, Hatzaki D, et al. Molecular epidemiology of noroviruses in children in South Greece, 2013–2015. J Med Virol, 2018;90(11):1703–1711.
33. van Beek J, de Graaf M, Al-Hello H, et al. NoroNet. Molecular surveillance of norovirus, 2005-16: an epidemiological analysis of data collected from the NoroNet network. Lancet Infect Dis, 2018;18(5):545–553.
34. Vinjé J. Advances in laboratory methods for detection and typing of norovirus. J Clin Microbiol, 2015;53(2):373–381.
35. Wollants E, De Coster S, Van Ranst M, et al. A decade of norovirus genetic diversity in Belgium. Infect Genet Evol, 2015;30:37–44.
36. Zhou H, Wang S, von Seidlein L, et al. The epidemiology of norovirus gastroenteritis in China: disease burden and distribution of genotypes. Front Med, 2020;14(1):1–7.
Labels
Hygiene and epidemiology Medical virology Clinical microbiologyArticle was published in
Epidemiology, Microbiology, Immunology
2021 Issue 4
Most read in this issue
- Mumps and its occurrence in the Czech Republic and Slovakia
- Possibilities for the analysis of peripheral blood B cell subpopulations in a routine immunological laboratory
- Corynebacterium sp. isolated from blood culture of a bacteremic patient. Will the assumptions about a new corynebacterium be confirmed?
- Prevalence and management of arterial hypertension in the population aged 25–64 in the Czech Republic with a focus on diabetic patients